CRDT.OB Insider Trading Activity and SEC Form 4 Filings
CRDT.OB insider trading summary
No open-market insider purchases or sales of Crdentia Corp (CRDT.OB) have been reported on SEC Form 4 in the past 12 months.
Latest CRDT.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 5, 2007 | John Kaiser | Chief Executive Officer | Buy | $10K (40,000 @ $0.25) |
| Dec 4, 2007 | John Kaiser | Chief Executive Officer | Buy | $5K (20,000 @ $0.25) |
| Oct 26, 2007 | Medcap Partners LP | 10% Owner | Buy | $715K (2,383,333 @ $0.30) |
| Oct 26, 2007 | C Fred Toney | Director | Buy | $715K (2,383,333 @ $0.30) |
| Oct 26, 2007 | Medcap Partners LP | 10% Owner | Buy | $635K (2,116,667 @ $0.30) |
| Oct 26, 2007 | C Fred Toney | Director | Buy | $500K (1,666,667 @ $0.30) |
| Oct 26, 2007 | C Fred Toney | Director | Buy | $635K (2,116,667 @ $0.30) |
| Aug 8, 2006 | James J Terbeest | Chief Financial Officer | Buy | $5K (5,000 @ $1.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.